Optometrists in Phillipsburg, KS Accepting Medicare

2 Optometrists found. Showing 1 - 2

Ronald J. Juenemann, O.d., P.a. Optometrist Medicare: Medicare Enrolled Practice Location: 655 5th Street, Phillipsburg, KS 67661 Phone: 785-543-2715    Fax: 785-543-6556

Mr. Ronald J Juenemann, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 655 5th Street, Phillipsburg, KS 67661 Phone: 785-543-2715    Fax: 785-543-6556

News Archive

Surgical treatment of hip or knee arthritis does not reduce obesity

A number of arthritis sufferers attribute their weight gain to inactivity due to a painful hip or knee. These patients may be disheartened when their post-operative weight either remains the same or increases.

Apotex launches generic Lipitor

Apotex Inc, a Canadian owned pharmaceutical company with headquarters in Toronto, launched today Apo-Atorvastatin, a generic version of 'Lipitor(R)' produced by Pfizer(R). This is the largest product to be genericized in Canadian history with approximate yearly sales of $1.2 billion. This last patent on Lipitor(R) will not expire until 2022. Apotex Inc. invented its own crystal form, thus overcoming the patents, 12 years ahead of time, which will result in close to $7 billion of cost-savings for the Canadian healthcare system.

Therapeutic-dose anticoagulation benefits moderately ill COVID-19 patients

Moderately ill patients hospitalized with COVID-19 have better chances of survival if treated with therapeutic-dose anticoagulation, according to an international study involving 121 sites, including UT Southwestern Medical Center.

Heart experts begin to test new device for treatment of blocked aortic valves

Heart experts at Johns Hopkins have begun testing a new device designed to replace blocked aortic valves in patients for whom traditional open-heart surgery is considered too risky, such as elderly patients and those with other serious medical conditions.

Cord Blood America announces highlights for 6-month period ended June 30, 2010

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced highlights for the six-month period ended June 30, 2010. The Company believes the period was the most significant and eventful in its history.

Read more Medical News

› Verified 8 days ago